Medhavi Gupta

Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review

J. Strosberg, R. Iyer, Kathryn M. Glaser, 2022, Cancers.

Emerging Systemic Therapies for Neuroendocrine Tumors

R. Iyer, Medhavi Gupta, Gillian Prinzing, 2021 .

Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer

K. Attwood, K. Takabe, S. Gandhi, 2022, Scientific Reports.

Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.

E. Petricoin, L. Matrisian, M. Pishvaian, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Exploring the role of survivin in neuroendocrine neoplasms

S. Yendamuri, Jingxin Qiu, K. Attwood, 2020, Oncotarget.

Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy

Ashutosh Kumar Singh, D. Hayes, S. Thota, 2022, JCO precision oncology.

Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future Implications

R. Iyer, C. Fountzilas, Medhavi Gupta, 2019, Cancers.

A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma

W. Bshara, R. Bies, K. Attwood, 2020, British Journal of Cancer.

Hepatocellular Carcinoma: Special Issue Highlights

R. Iyer, Medhavi Gupta, 2020, Cancers.